Maryville University Nursing 615 Exam 3
Review
Low-dose colchine - ANS-1.2 mg at first sign of flare, followed by 0.6 mg one hour later
for a total dose of 1.8 mg.
High-dose colchine - ANS-1.2 mg followed by 0.6 mg every 4-6 hours totaling 4.8 mg.
Gout - ANS-BUN, creatinine, and creatinine clearance should be monitored in the
treatment of this disease
Colchine - ANS-This medication can cause severe diarrhea, nausea, vomiting,
abdominal pain
Febuxostat (Uloric) - ANS-When prescribing this medication, patients should be taught
that gout may worsen with therapy before it improves
Corticosteroids - ANS-These medications can cause the following adverse effects if
taken for six months or more: Osteoporosis and poor diabetic control. Patients should
report black, tarry stools or abdominal pain.
Corticosteroids - ANS-These medications should be tapered to avoid recurrent activity
of the underlying disease and possible cortisol deficiency resulting from the
hypothalamic-pituitary-adrenal axis suppression during the period of steroid therapy.
Black Box Warning on NSAIDS - ANS-Increased risk of serious cardiovascular
thrombotic events, such as myocardial infarction and stroke. These medications can
also cause serious GI events such as bleeding, ulceration or perforation of stomach or
intestines, which can be fatal.
Pain management - ANS-When treating this common issue, it is recommended to begin
with NSAIDS and work up from there as needed
Ibuprofen - ANS-This medication works by inhibiting the COX enzymes; however, the
exact mechanism of action for this particular medication is unknown.
Acetaminophen - ANS-A serious adverse effect related to this medication is referred to
as "------------- poisoning"
, Symptoms of hypoglycemia - ANS-Decreased LOC, hunger, diaphoresis, weakness,
dizziness and tachycardia
Symptoms of hyperglycemia - ANS-Polyuria, polydipsia and polyphagia (weight loss)
Symptoms of DKA - ANS-Kussmaul's respiration, ketone odor of the breath (fruity
breath), vomiting, dehydration, abdominal pain, and neurologic symptoms such as
lethargy; can progress to coma in later stages if left untreated.
Metformin - ANS-This medication decreases hepatic glucose output inhibiting
gluconeogenesis. It also increases insulin mediated glucose utilization in peripheral
tissues. This medication decreases intestinal absorption of glucose. This medication
may also be used in diabetics to decrease cholesterol and triglyceride levels.
Metformin - ANS-When patients are prescribed this medication, the primary care
provider should assess serum creatinine, renal function, and creatinine clearance
initially and annually.
Gliptins (DPP4 inhibitors) - ANS-These medications increase the incretin levels, which
inhibit glucagon release; this subsequently increases insulin secretion, decreases
gastric emptying and decreases blood glucose levels.
GLP-1 agonists - ANS-These medications bind directly to the GLP-1 receptor, which
then slows gastric emptying and increases insulin secretion by pancreatic beta cells.
Exenatide (Byetta) - ANS-This medication should be administered 60 minutes before
breakfast and dinner.
PTU - ANS-Adverse effects of this medication include fatal granuloctyopenia (presents
as fever and slow throat), vasculitis, temporary alopecia, rash, aplastic anemia, and
acute renal failure.
Levothyroxine - ANS-Adverse effects of this medication include tachycardia and angina,
which are more noticable in the elderly.
Methimazole - ANS-This medication is the recommended treatment of toxic goiter
Methimazole - ANS-This medication is tetratogenic and may cause the fetus to get
aplasia acutis.
Review
Low-dose colchine - ANS-1.2 mg at first sign of flare, followed by 0.6 mg one hour later
for a total dose of 1.8 mg.
High-dose colchine - ANS-1.2 mg followed by 0.6 mg every 4-6 hours totaling 4.8 mg.
Gout - ANS-BUN, creatinine, and creatinine clearance should be monitored in the
treatment of this disease
Colchine - ANS-This medication can cause severe diarrhea, nausea, vomiting,
abdominal pain
Febuxostat (Uloric) - ANS-When prescribing this medication, patients should be taught
that gout may worsen with therapy before it improves
Corticosteroids - ANS-These medications can cause the following adverse effects if
taken for six months or more: Osteoporosis and poor diabetic control. Patients should
report black, tarry stools or abdominal pain.
Corticosteroids - ANS-These medications should be tapered to avoid recurrent activity
of the underlying disease and possible cortisol deficiency resulting from the
hypothalamic-pituitary-adrenal axis suppression during the period of steroid therapy.
Black Box Warning on NSAIDS - ANS-Increased risk of serious cardiovascular
thrombotic events, such as myocardial infarction and stroke. These medications can
also cause serious GI events such as bleeding, ulceration or perforation of stomach or
intestines, which can be fatal.
Pain management - ANS-When treating this common issue, it is recommended to begin
with NSAIDS and work up from there as needed
Ibuprofen - ANS-This medication works by inhibiting the COX enzymes; however, the
exact mechanism of action for this particular medication is unknown.
Acetaminophen - ANS-A serious adverse effect related to this medication is referred to
as "------------- poisoning"
, Symptoms of hypoglycemia - ANS-Decreased LOC, hunger, diaphoresis, weakness,
dizziness and tachycardia
Symptoms of hyperglycemia - ANS-Polyuria, polydipsia and polyphagia (weight loss)
Symptoms of DKA - ANS-Kussmaul's respiration, ketone odor of the breath (fruity
breath), vomiting, dehydration, abdominal pain, and neurologic symptoms such as
lethargy; can progress to coma in later stages if left untreated.
Metformin - ANS-This medication decreases hepatic glucose output inhibiting
gluconeogenesis. It also increases insulin mediated glucose utilization in peripheral
tissues. This medication decreases intestinal absorption of glucose. This medication
may also be used in diabetics to decrease cholesterol and triglyceride levels.
Metformin - ANS-When patients are prescribed this medication, the primary care
provider should assess serum creatinine, renal function, and creatinine clearance
initially and annually.
Gliptins (DPP4 inhibitors) - ANS-These medications increase the incretin levels, which
inhibit glucagon release; this subsequently increases insulin secretion, decreases
gastric emptying and decreases blood glucose levels.
GLP-1 agonists - ANS-These medications bind directly to the GLP-1 receptor, which
then slows gastric emptying and increases insulin secretion by pancreatic beta cells.
Exenatide (Byetta) - ANS-This medication should be administered 60 minutes before
breakfast and dinner.
PTU - ANS-Adverse effects of this medication include fatal granuloctyopenia (presents
as fever and slow throat), vasculitis, temporary alopecia, rash, aplastic anemia, and
acute renal failure.
Levothyroxine - ANS-Adverse effects of this medication include tachycardia and angina,
which are more noticable in the elderly.
Methimazole - ANS-This medication is the recommended treatment of toxic goiter
Methimazole - ANS-This medication is tetratogenic and may cause the fetus to get
aplasia acutis.
